Equities

Oxford Biodynamics PLC

OBD:LSE

Oxford Biodynamics PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)3.19
  • Today's Change-0.01 / -0.31%
  • Shares traded1.48m
  • 1 Year change-89.61%
  • Beta1.6217
Data delayed at least 20 minutes, as of Sep 27 2024 16:35 BST.
More ▼

Profile data is unavailable for this security.

About the company

Oxford BioDynamics Plc is a United Kingdom-based biotechnology company developing medicine tests for immune health based on the EpiSwitch 3D genomics platform. The Company is primarily engaged in the commercialization of proprietary molecular diagnostics products and biomarker research and development. Its products include EpiSwitch CiRT, EpiSwitch CST, EpiSwitch PSE, and EpiSwitch Explorer. The EpiSwitch CiRT is a blood test, which predicts an individual patient’s therapeutic response to checkpoint inhibitor immunotherapy. The EpiSwitch CST is a blood test for the prediction of COVID-19 severity in any adult. The EpiSwitch Explorer is a microarray kit for high-throughput, high-resolution 3D genome profiling. The EpiSwitch platform offers reproducibly translating 3D genome regulation for clinical application. This platform provides a portfolio of clinical smart tests based on EpiSwitch technology.

  • Revenue in GBP (TTM)617.00k
  • Net income in GBP-11.11m
  • Incorporated2007
  • Employees45.00
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
ValiRx Plc9.60k-2.04m2.62m8.002.62m8.00
TheraCryf PLC396.00k-3.14m2.93m9.002.93m9.00
Fusion Antibodies PLC1.14m-2.23m3.36m31.003.36m31.00
IXICO PLC6.00m-1.87m4.49m89.004.49m89.00
ImmuPharma PLC-69.96k-2.46m6.28m5.006.28m5.00
Genflow Biosciences PLC0.00-1.63m7.44m5.007.44m5.00
Synairgen plc0.00-6.92m7.67m36.007.67m36.00
Cizzle Biotechnology Holdings PLC0.00-1.72m7.75m67.007.75m67.00
LungLife AI Inc21.69k-3.34m8.50m15.008.50m15.00
Oxford Biodynamics PLC617.00k-11.11m11.91m45.0011.91m45.00
OptiBiotix Health PLC644.00k-2.04m16.53m5.0016.53m5.00
Hemogenyx Pharmaceuticals PLC0.00-6.69m20.67m17.0020.67m17.00
Data as of Sep 27 2024. Currency figures normalised to Oxford Biodynamics PLC's reporting currency: UK Pound GBX

Institutional shareholders

45.23%Per cent of shares held by top holders
HolderShares% Held
Vulpes Investment Management Pte Ltd.as of 08 Apr 202429.65m9.51%
Arbuthnot Latham & Co. Ltd.as of 01 Jul 202426.24m8.41%
Unicorn Asset Management Ltd.as of 08 Apr 202425.13m8.06%
Lombard Odier Asset Management (Europe) Ltd.as of 21 Aug 202415.75m5.05%
KW Investment Management Ltd.as of 01 Jul 202414.20m4.55%
Cantor Fitzgerald Europeas of 05 Apr 20248.02m2.57%
Investec Wealth & Investment Ltd.as of 15 Jan 20247.32m2.35%
Hargreaves Lansdown Asset Management Ltd.as of 01 Jul 20245.47m1.75%
Armistice Capital LLCas of 04 Feb 20224.93m1.58%
Chelverton Asset Management Ltd.as of 01 Jul 20244.33m1.39%
More ▼
Data from 11 Apr 2024 - 03 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.